Harbinger Capital
www.harbert.net/capital-partnersHarbinger Capital is a multi-billion dollar hedge fund founded in 2001 and is led by its Co-Founder and Chief Investment Officer, Philip Falcone, who has over 20 years of investment experience across an array of market cycles. The Harbinger Team is disciplined and value oriented, focusing on alpha generating ideas that are uncorrelated to investment cycles. The firm combines a flexible, innovative approach to uncovering opportunity with a thorough investment process. Each investment undergoes rigorous fundamental research, extensive vetting, and seeks an identifiable catalyst for value realization. Harbinger regards risk management as a critical component of the investment process and actively manages risk at three levels: portfolio, position and operations. The firm offers several strategies which emphasize different opportunities, each based on the same time-tested fundamental investment and risk management processes.
View Older Stories
-
HC2 Holdings Reports Third Quarter 2019 Results
-
HC2's Marine Services Segment Announces Sale of Huawei Marine Networks Joint Venture
-
HC2 Broadcasting Completes $79 Million Financing
-
HC2 Holdings to Announce Third Quarter 2019 Financial Results
-
HC2 Holdings Reports Second Quarter 2019 Results
-
Pansend Life Sciences’ Portfolio Company MediBeacon Announces $30 Million Investment from Huadong Medicine and Exclusive Commercialization Partnership in Greater China
-
HC2 Holdings to Announce Second Quarter 2019 Financial Results
-
Wall Street takes on long-term care payouts as insurers balk at costs
-
Pansend Life Sciences’ Portfolio Company, R2 Dermatology, Enters Into Exclusive China/Asia-Pacific Distribution Agreement
-
HC2 Holdings Reports First Quarter 2019 Results
-
HC2 Holdings to Announce First Quarter 2019 Financial Results
-
Tredegar Reports Fourth Quarter and Full Year 2018 Results
-
HC2 Holdings Reports Fourth Quarter and Full Year 2018 Results
-
HC2 Holdings to Announce Fourth Quarter and Fiscal Year 2018 Financial Results
-
Fred's (FRED) Names Joseph Anto as CEO
-
Fred's, Inc. Announces Appointment of Chief Executive Officer and Other Key Leadership Changes
-
HC2 Portfolio Company DBM Global Inc. Completes Acquisition of GrayWolf Industrial
-
Tredegar Reports Third-Quarter 2018 Results
-
HC2 Holdings Reports Third Quarter 2018 Results
-
HC2 Holdings Sets Third Quarter 2018 Earnings Release Date And Webcast
-
HC2 Holdings (HCHC) to Explore Strategic Alternatives for Global Marine Subsidiary
-
HC2 to Explore Strategic Alternatives for Global Marine Subsidiary
-
MediBeacon Inc. Granted FDA Breakthrough Device Designation for Transdermal GFR Measurement System
-
HC2 Portfolio Company MediBeacon™ Granted Breakthrough Device Status From FDA for Transdermal GFR Measurement System
-
FDA Grants Breakthrough Device Status for MediBeacon's Transdermal GFR Measurement System
-
HC2 Portfolio Company DBM Global Inc. To Acquire GrayWolf Industrial, A Leading Provider Of Specialty Maintenance, Repair And Installation Services
-
HC2 Broadcasting Launches Network Partnership With The Christian Broadcasting Network
-
Harbinger hedge fund manager to pay $30 million in New York tax accord
-
Parent Company of HC2 Telecom Subsidiary PTGi-ICS Changes Name to ICS Group Holdings Inc.
-
HC2 Portfolio Company Continental General Insurance Completes Acquisition of $2.4 Billion Long-Term Care Insurance Business From Humana Inc.
-
HC2 Holdings Reports Second Quarter 2018 Results
-
Tredegar Reports Second-Quarter 2018 Results
-
HC2 Holdings Sets Second Quarter 2018 Earnings Release Date and Webcast
-
Jones Energy (JONE) Names Carl Giesler Jr. as New CEO; Appoints Stephen Jones to Board
-
Jones Energy, Inc. Appoints New Chief Executive Officer and Announces Changes to the Board of Directors
-
Communications Strategy and Policy Expert Rebecca Hanson Joins HC2 Broadcasting Subsidiary
-
James P. McGinnis Joins PJ SOLOMON as Managing Director to Expand Renewables Coverage
-
James P. McGinnis Joins PJ SOLOMON as Managing Director to Expand Renewables Coverage
-
HC2 Completes Sale of Pansend Life Sciences Portfolio Company BeneVir Biopharm to Janssen Biotech, Inc. for Up to $1.04 Billion
-
HC2 Holdings Reports First Quarter 2018 Results
-
HC2 Holdings (HCHC) Says Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech (JNJ) for up to $1.04 Billion
-
HC2 Announces Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech, Inc. for up to $1.04 Billion
-
Fred's (FRED) Appoints Joseph Anto Interim CEO; Michael K. Bloom Resigns To Pursue Other Opportunities
-
Fred’s, Inc. Appoints Joseph Anto Interim Chief Executive Officer
-
Executive Chairman David Maura Named Chief Executive Officer of Spectrum Brands Holdings
-
HC2 Holdings Sets First Quarter 2018 Earnings Release Date and Webcast
-
In Vietnam, a mega casino rises with the help of a Macau junket company
-
Stroock's Private Funds Group Adds Former Investment Management GC and Compliance Counselor Michael Emanuel as Partner in New York
-
HC2 Holdings Reports Fourth Quarter and Full Year 2017 Results
-
HC2 Holdings Sets Fourth Quarter and Fiscal Year 2017 Earnings Release Date and Webcast